Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell–depleted lymphoma after CART therapy
Author(s) -
Djordje Atanackovic,
Tim Luetkens,
Destiny Omili,
Thierry Iraguha,
Forat Lutfi,
Nancy M. Hardy,
Xiaoxuan Fan,
Stephanie V. Avila,
Kapil Saharia,
Jennifer Husson,
Silke V. Niederhaus,
Philip Margiotta,
Seung Tae Lee,
Jennie Y. Law,
Heather D. Mannuel,
Erica R. Vander Mause,
Sherri Bauman,
Patricia Lesho,
Kim G. Hankey,
John W. Baddley,
Mehmet H. Kocoglu,
Jean A. Yared,
Aaron P. Rapoport,
Saurabh Dahiya
Publication year - 2022
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2022016175
Subject(s) - hypogammaglobulinemia , lymphoma , cd19 , b cell , immunology , medicine , t cell , virology , cell , immune system , biology , antibody , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom